Chlamydia protein, sequence and uses thereof

Details Chlamydia protein, sequence and uses thereof Chlamydia protein, sequence and uses thereof

1997-10-02

2008-12-02

Stucker, Jeffrey (Department: 1649)

Chemistry: natural resins or derivatives; peptides or proteins;

Proteins, i.e., more than 100 amino acid residues

C536S023100

Reexamination Certificate

active

07459524

ABSTRACT:
A high molecular weight (“HMW”) protein ofChlamydia, the amino acid sequence thereof, and antibodies that specifically bind the HMW protein are disclosed as well as the nucleic acid sequence encoding the same. Also disclosed are prophylactic and therapeutic compositions, comprising the HMW protein, a fragment thereof, or an antibody that specifically binds the HMW protein or a portion thereof, or the nucleotide sequence encoding the HMW protein or a fragment thereof, including vaccines.

REFERENCES:
patent: 4427782 (1984-01-01), Caldwell et al.
patent: 4855283 (1989-08-01), Lockhoff et al.
patent: 4935352 (1990-06-01), Igarashi et al.
patent: 5071962 (1991-12-01), Morrison et al.
patent: 5516638 (1996-05-01), Urnovitz et al.
patent: 5565352 (1996-10-01), Hochstrasser et al.
patent: 5629167 (1997-05-01), Ratti
patent: 5725863 (1998-03-01), Daniels et al.
patent: 5849306 (1998-12-01), Sim et al.
patent: 5871977 (1999-02-01), Kubota et al.
patent: 5965141 (1999-10-01), Briles et al.
patent: 5976544 (1999-11-01), Charles et al.
patent: 6077693 (2000-06-01), Tang et al.
patent: 6565856 (2003-05-01), Skeiky et al.
patent: 6642023 (2003-11-01), Jackson et al.
patent: 6887843 (2005-05-01), Jackson et al.
patent: 2004/0037846 (2004-02-01), Jackson
patent: 2004/0067524 (2004-04-01), Jackson et al.
patent: 2004/0137005 (2004-07-01), Jackson et al.
patent: 2005/0048557 (2005-03-01), Jackson et al.
patent: 2005/0281847 (2005-12-01), Berthet et al.
patent: EP 0 818 681 (1998-01-01), None
patent: WO 94/01548 (1994-01-01), None
patent: WO 95/12411 (1995-05-01), None
patent: WO 96/31236 (1996-10-01), None
patent: WO 98/10789 (1998-03-01), None
patent: WO 99/28475 (1999-06-01), None
patent: WO 99/31236 (1999-06-01), None
patent: WO 00/34483 (2000-06-01), None
patent: WO 01/40474 (2001-06-01), None
patent: WO 02/08267 (2002-01-01), None
Sexton et al., J. of Immunol., 152(4):1861-72, 1994.
Choh et al., PNAS 77(6):3211-14, 1980.
Su et al., PNAS 93:11143-48, 1996.
Buenida et al., FEMS Microbiol. Lttrs., May 1, 150(1):113-119, 1997.
DeSa et al., Infection & Immunity, Dec., 63(12):4912-16, 1995.
Birkelund et al., Infection & Immunity, 56(3):654-59, Mar, 1988.
Webster's New World, Third, 1988, pp. 675 and 1472.
Mygind et al., FEMS Microbiol. Lttrs, 186:163-169, 2000.
ATCC accession No. VR-902BChlamydia trachomatis(Busacca) Rake, Lymphogranuloma venereum (LGV II) strain 434.
Pal et al., Infection and Immunity Aug., 1997, 65(8):3361-3369.
Short Protocols in Molecular Biology, Ausubel F.M., ed., 1997, John Wiley & Sons, Inc., pp. 10-1 thru 10-4.
Wells et al. Biochemistry 29: 8509-8517, 1990.
Ngo et al. the Protein Folding Problem and Tertiary Structure Prediction, 492-495, 1994.
Bork et al. Genome Res 10: 398-400, 2000.
Skolnick et al. Trends in Biothech 18: 34-39, 2000.
Doerks et al. Trends in Genetics 14: 248-250, 1998.
Smith et al. Nature Biotechnology 15: 1222-1223, 1997.
Brenner SE. Trends in Genetics 15: 132-133, 1999.
Bork et al. Trends in Genetics 12: 425-427, 1996.
Tuffrey et al., J Gen Microbiol 138 Pt 8: 1707-1715, 1992.
Clyne et al., J Biolumin Chemilumin 4(1): 357-366, 1989.
Caldwell, et al., Infec. Immun., 31(3):1161-1176 (1981).
Cerrone et al., Infec. Immun., 59(1):79-90 (1991).
Chen et al., Molecular Microbiology 11(3):501-507 (1994).
Murdin et al., Infec. Immun., 63(3):1116-1121 (1995).
Murdin et al., Infec. Immun., 61(10):4406-4414 (1993).
Swanson et al., Infec. Immun., 38(2):502-507 (1990).
Wagar et al., Infec. Immun., 56(7):1678-1684 (1988).
Zhang et al., Cell, 69:861-869 (1992).
Caldwell et al., 1981, “Purification and partial characterization of the major outer membrane protein ofChlamydia trachomatis”, Infect. and Immun. 31:1161-1176.
Herring et al., FEMS Microbiol Letts. 65:153-158 (1989).
Tan et al., Infect Immun. 58(9) 3101-3108 (1990).
Zhang et al., Nucleic Acids Res. 18(4):1061 (1990).
Stephens et al., J. Bacteriol 168:1277-82 (1986).
Deslauriers et al., Infect. Immun. vol. 64: No. 2; p. 434-440 (1996).
Carlson et al., Infect Immun. vol. 65: No. 6; p. 2080-2087 (1997).
Amersdorfer, P., et al. 1997. Molecular characterization of murine humoral immune response to botulinum neurotoxin type A binding domain as assessed by using phage antibody libraries. Infect Immun 65(9):3743-52.
Barenkamp, S.J., et al. 1996. Identification of suface-exposed B-cell epitopes on high molecular-weight adhesion proteins of nontypeable Haemophilus influenzae. Infect Immun 64(8):3032-7.
Batteiger, B.E., et al. 1996. Species-, serogroup-, and serovar-specific epitopes are juxtaposed in variable sequence region 4 of the major outer membrane proteins of someChalamydia trachomatisserovars, Infec Immun 64(7):2839-41.
Baughn, R.E., et al. 1996. Epitope mapping of B-cell determinants on the 15-kilodalton lipoprotein of Treponema pallidum (Tpp15) with synthetic peptides. Infect Immun 64(7):2457-66.
Brown, D. R., et al. 1997. Identification and characterization of a neutralizing monoclonal antibody against botulinum neurotoxin serotype F, following vaccination with active toxin. Hybridoma 16(5):447-56.
Buendia, A. J., et al. 1997. Localization by immunoelectron microscopy of antigens ofChlamydia psittacisuitable for diagnosis or vaccine development. FEMS Microbiol Lett 150(1):113-9.
Burnie, J. P., et al. 1996. Defining antibody targets inStreptococcus oralisinfection. Infect Immun 64(5):1600-8.
Cunningham, M.W., et al. 1997. Molecular analysis of human cardiac myosin-cross-reactive B- and T-cell epitopes of the group A steptococcal M5 protein. Infect Immun 65(9):3913-23.
Davies, D.R., et al. 1996. Interactions of protein antigens with antibodies. Proc Natl Acad Sci USA 93(1):7-12.
De Sa, C. 1996. The major outer-membrane protein of Chlamydia: structure and functions. Vet Res 27(4-5):317-31, French, no translation.
Delvig, A.A., et al. 1996. Immune responses to linear epitopes on the PorB protein ofNeisseria meningitidisin patients with systemic meningococcal disease. Microbiology 142(Pt9):2491-8.
Duim, B., et al. 1996. Fine mapping of outer membrane protein P2 antigenic sites which vary during persistent infection by Haemophilus influenzae. Infect Immun 64(11):4673-9.
Fan, J., et al. 1997. Antigen conformation dependence ofChlamydia trachomatisinfectivity neutralization. J Infect Dis 176(3):713-21.
Ghadjari, A., et al. 1997. Epitope mapping Candida albicans proteinase (SAP 2). FEMS Immunol Med Microbiol 19(2):115-23.
Janeway, C. A., et al. 1990. Immunogenicity: proceedings of UCLA Symposium held at Steamboat Springs, Colorado, Jan. 21-28, 1989. Alan R. Liss, Inc., New York, NY.
Lainson, F.A., et al. 1996. Characterization of epitopes involved in the neutralization ofPasteurella haemolyticaserotype A1 leukotoxin. Microbiology 142(Pt9):2499-507.
Mechin, M.C., et al., 1996. Identification of surface-exposed linear B-cell epitopes of the nonfimbrial adhesin CS31A ofEscherichia coliby using overlapping peptides and antipeptide antibodies. Infect Immun 64(9):3555-64.
Morris, Glenn E. (editor). 1996. Epitope Mapping Protocols vol. 66. Humana Press, Totowa, N.J.
Oettinger T., et al. 1997. Characterization of the delayed type hypersensitivity-inducing epitope of MPT64 from Mycobacterium tuberculosis. Scand J Immunol 45(5):499-503.
Pal S., et al. 1997. Monoclonal immunoglobulin A antibody to the major outer membrane protein of theChlamydia trachomatismouse pneumonitis biovar protects mice against a chlamydial genital challenge. Vaccine 15(5):575-82.
Read, T.D., et al. 2003. Genome sequence ofChlamydophila caviae(Chlamydia psittaciGPIC): examining the role of niche-specific genes in the evolution of the Chlamydiaceae. Nucleic Acids Res 31(8):2134-2147.
Roitt, I., et al. 1989. Immunology, 2ndEdition, 7 Antigen Recognition. Gower Medical Publishing, London, England Chapter 7:7.1-7.10.
Saint-Remy, J.M. 1997. Epitope mapping: a new method for biological evaluation and immunotoxicology. Toxicology 119(1):77-81.
Sandbulte, J., et al. 1996. Evaluation ofChlamydia psittacisubfraction and subunit preparations for their protective capacities. Vet Microbiol 48(3-4):269-82.
Stephens, R., et

Affiliated with

Also associated with

Rating

Chlamydia protein, sequence and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Chlamydia protein, sequence and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Chlamydia protein, sequence and uses thereof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4028874